Today at Pfizer´s annual shareholder meeting
Chairman and Chief Executive Officer Jeffrey B. Kindler detailed his
plan to build on the Company´s foundation to
drive greater shareholder return.
"Operationally, in 2007, we took a series of
significant actions to better position Pfizer to meet our challenges and
to seize the many opportunities before us in the growing global
marketplace for better healthcare," Mr.
Kindler said. "Of course, we are far from done "“ and our progress is not yet reflected in the share price."
At the meeting, the company´s 14 directors
were re-elected to one-year terms. In other voting, shareholders
ratified the selection of KPMG as Pfizer´s
independent registered public accounting firm for the 2008 fiscal year.
The two shareholder resolutions did not receive a majority vote.
